Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Comparing the PLCO and ERSPC trials on efficacy of prostate cancer screening

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Comparing the PLCO and ERSPC trials on efficacy of prostate cancer screening ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
3 Oct 2013

Prevention benefit from vitamin D

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Prevention benefit from vitamin D ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
3 Oct 2013

Observational RASTER study on the 70-gene-signature

Dr Caroline Drukker - Netherlands Cancer Institute, Amsterdam
Observational RASTER study on the 70-gene-signature ( Dr Caroline Drukker - Netherlands Cancer Institute, Amsterdam )
3 Oct 2013

The 'Make Sense Campaign' for head and neck cancer awareness

Prof René Leemans - General Secretary of the European Head and Neck Society
The 'Make Sense Campaign' for head and neck cancer awareness ( Prof René Leemans - General Secretary of the European Head and Neck Society )
2 Oct 2013

Comment on prostate cancer screening from the ECC 2013 Scientific Co-Chair

Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy
Comment on prostate cancer screening from the ECC 2013 Scientific Co-Chair ( Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy )
30 Sep 2013

Comment on primary site tumours from the ECC 2013 Scientific Co-Chair

Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy
Comment on primary site tumours from the ECC 2013 Scientific Co-Chair ( Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy )
30 Sep 2013

Identifying disease-causing mechanisms in cancers with unknown primary site improves treatment and survival

Dr Zoran Gatalica - Caris Life Sciences, Phoenix, USA
Identifying disease-causing mechanisms in cancers with unknown primary site improves treatment and survival ( Dr Zoran Gatalica - Caris Life Sciences, Phoenix, USA )
29 Sep 2013

Prostate-specific antigen test 'does more harm than good'

Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France
Prostate-specific antigen test 'does more harm than good' ( Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France )
29 Sep 2013

Prostate-specific antigen test 'does more harm than good'

Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France
Prostate-specific antigen test 'does more harm than good' ( Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France )
29 Sep 2013

Identifying disease-causing mechanisms in cancers with unknown primary site i

Dr Zoran Gatalica - Caris Life Sciences, Phoenix, USA
Identifying disease-causing mechanisms in cancers with unknown primary site i ( Dr Zoran Gatalica - Caris Life Sciences, Phoenix, USA )
29 Sep 2013

Fall in colorectal cancer death rates attributed to screening

Prof Philippe Autier - International Prevention Research Institute, Lyon, France
Fall in colorectal cancer death rates attributed to screening ( Prof Philippe Autier - International Prevention Research Institute, Lyon, France )
28 Sep 2013

Evidence that fall in colorectal cancer death rates is attributable to screening programmes

Prof Philippe Autier - International Prevention Research Institute, Lyon, France
Evidence that fall in colorectal cancer death rates is attributable to screening programmes ( Prof Philippe Autier - International Prevention Research Institute, Lyon, France )
28 Sep 2013